iVascular
Enric Santodomingo i Tresserras has a diverse work experience, starting in 2011 with an internship as a Consultant at IESE Business School. From September 2011 to September 2012, they worked as a Junior Consultant at F. Iniciativas. Since January 2013, Enric has been working at iVascular as the Chief Financial Officer Deputy.
Enric Santodomingo i Tresserras's education history includes obtaining a Master's degree in Financial Management from Esade. Enric also completed an Executive Program in Mergers & Acquisitions from the NYU Stern School of Business. Prior to that, they obtained a Licenciatura degree in Business Administration and Management, specializing in Administration and Management of Companies from Universitat de Barcelona. Additionally, they completed a Diplomatura in Business Sciences with a focus on Finance and Financial Management Services, also from Universitat de Barcelona.
This person is not in any offices
iVascular
1 followers
The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to info@ivascular.global